Journal of Cancer Research and Therapeutics Close
 

Figure 2: Final processed images by Angiosys 2.0 showing angiogenesis in the chick chorioallantoic membranes subjected to normal saline (a), zinc 2.5 μg/embryo (b), sorafenib 2 μg/embryo (c), zinc 2.5 μg/embryo + sorafenib 2 μg/embryo (d), and zinc 2.5 μg/embryo + sorafenib 1 μg/embryo (e)

Figure 2: Final processed images by Angiosys 2.0 showing angiogenesis in the chick chorioallantoic membranes subjected to normal saline (a), zinc 2.5 μg/embryo (b), sorafenib 2 μg/embryo (c), zinc 2.5 μg/embryo + sorafenib 2 μg/embryo (d), and zinc 2.5 μg/embryo + sorafenib 1 μg/embryo (e)